AGP
MREO

Artia Global Partners’s Mereo BioPharma MREO Stock Holding History

Artia Global Partners’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-475,361
Closed -$979K – 63
2025
Q3 		$979K Hold
475,361
– – 0.16% 44
2025
Q2 		$1.29M Buy
475,361
+54,002
+13% +$130K 0.31% 28
2025
Q1 		$948K Hold
421,359
– – 0.24% 32
2024
Q4 		$1.47M Hold
421,359
– – 0.53% 29
2024
Q3 		$1.73M Hold
421,359
– – 0.47% 23
2024
Q2 		$1.52M Hold
421,359
– – 0.29% 31
2024
Q1 		$1.39M Buy
+421,359
New +$1.43M 0.28% 34

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Artia Global Partners's MREO Position: Q4 2025 in Review

Artia Global Partners sold out of Mereo BioPharma (MREO) in Q4 2025, closing a stake of 475,361 shares — an estimated $979K sold.

Artia Global Partners first reported a position in MREO in Q1 2024 and held it in 7 quarters. The position peaked at $1.73M in Q3 2024. 70 funds tracked by Wall St. Rank hold MREO as of Q4 2025.

  • Artia Global Partners reported no remaining Mereo BioPharma position as of Q4 2025 after selling out during the quarter.
  • Artia Global Partners sold 475,361 Mereo BioPharma shares in Q4 2025, an estimated $979K.
  • Artia Global Partners first reported a position in Mereo BioPharma in Q1 2024 and held it in 7 quarters.
  • Artia Global Partners's Mereo BioPharma position peaked at $1.73M in Q3 2024.
  • 70 funds tracked by Wall St. Rank held Mereo BioPharma as of Q4 2025.

Based on Artia Global Partners's 13F filing for Q4 2025, filed 17 Feb 2026.